MAPT and Parkinson disease: Novel Drug Classes Targeting Protein Aggregation: In diseases like Alzheimer’s and Parkinson’s, misfolded proteins such as amyloid-β, tau, and α-synuclein form harmful clumps that contribute to neurodegeneration [223].